Commentary: Unmet Needs in Generalized Pustular Psoriasis in Clinical Practice

Balato, Anna; Ambrogio, Francesca; Burlando, Martina; Carrera, Carlo Giovanni; Chiricozzi, Andrea; Esposito, Maria; Piaserico, Stefano; Teoli, Miriam; Gisondi, Paolo

doi:10.1007/s13555-023-01073-0

Dermatol Ther (Heidelb)

2023

DOI: 10.1007/s13555-023-01073-0

|View full text |Cite

Commentary: Unmet Needs in Generalized Pustular Psoriasis in Clinical Practice

Anna Balato,

Francesca Ambrogio,

Martina Burlando

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article2

Relationship

Self Cite1

Independent1

Authors

Journals

Cited by 2 publications

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Clinical course and disease burden of patients with generalized pustular psoriasis in Portugal: a multicenter retrospective cohort study

Torres,

Antunes,

Brasileiro

et al. 2024

Journal of Dermatological Treatment

View full text Add to dashboard Cite

Clinical course and disease burden of patients with generalized pustular psoriasis in Portugal: a multicenter retrospective cohort study

Torres,

Antunes,

Brasileiro

et al. 2024

Journal of Dermatological Treatment

View full text Add to dashboard Cite

Generalized pustular psoriasis successfully treated with spesolimab: A case report

Brigenti,

Gisondi,

Bellinato

et al. 2024

SAGE Open Medical Case Reports

Self Cite

View full text Add to dashboard Cite

Generalized pustular psoriasis is defined as a primary, sterile, macroscopically visible pustular eruption on non-acral skin, which can occur with or without systemic inflammation and/or psoriasis vulgaris, and can either be relapsing or be persistent, according to the European Rare and Severe Psoriasis Expert Network. The treatment of generalized pustular psoriasis may be challenging. We describe a 48-year-old woman with a 15-year history of severe generalized pustular psoriasis and plaque psoriasis resistant to multiple courses of treatments with conventional and biological agents who had a rapid, complete and durable (up to 12 months) clinical remission with spesolimab, an anti-interleukin-36 receptor antagonist monoclonal antibody recently approved for the treatment of generalized pustular psoriasis flares.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Commentary: Unmet Needs in Generalized Pustular Psoriasis in Clinical Practice

Cited by 2 publications

References 34 publications

Clinical course and disease burden of patients with generalized pustular psoriasis in Portugal: a multicenter retrospective cohort study

Clinical course and disease burden of patients with generalized pustular psoriasis in Portugal: a multicenter retrospective cohort study

Generalized pustular psoriasis successfully treated with spesolimab: A case report

Contact Info

Product

Resources

About